In CRC tissues and cells, the downregulation of LINC00689 and upregulation of its downstream target miR-31-5p degrades LATS2, activates the YAP1/β-catenin signaling pathway, and accelerates the development of CRC. Here, LINC00689 is linked to colorectal carcinoma.